Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

intervention

intervention is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 9
Pipeline programs 56
News articles 0
Drug details — intervention
Class
—
Route
—
Patents
9
Programs
56
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

intervention is an FDA-listed pharmaceutical active ingredient.

Key facts

INN intervention

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. Brief motivational intervention Phase 3 · BRIGHT MINDS BIOSCIENCES · Drug Use
  2. Drug use prevention intervention Phase 3 · BRIGHT MINDS BIOSCIENCES · Adolescent Behavior
  3. Educational Intervention Phase 3 · United Therapeutics Europe · Hematologic Malignancies
  4. HEPARIN , NADROPARIN Phase 3 · Disc Medicine · All patients who receive ECMO treatment during the study per
  5. Intervention Phase 3 · Chinese Academy of · HIV
  6. Intervention - a validated home BP monitor and support from the specialist nurse Phase 3 · United Therapeutics Europe · Stroke
  7. Peer Mentoring Intervention for HCV-Infected IDUs Phase 3 · BRIGHT MINDS BIOSCIENCES · Hepatitis C
  8. Standard Brief Intervention Phase 3 · BRIGHT MINDS BIOSCIENCES · Drug Usage

Related patents

Browse patents

  1. US 10874748

    Intervention for tendinopathy

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10525106

    Angiopoietin-based interventions for treating cerebral malaria

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10251938

    Angiopoietin-based interventions for treating cerebral malaria

    Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9968653

    Angiopoietin-based interventions for treating cerebral malaria

    Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9639665

    Methods for diagnosis and intervention of hepatic disorders

    Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9592271

    Angiopoietin-based interventions for treating cerebral malaria

    Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9457070

    Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease

    Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8613904

    Methods for diagnosis and intervention of hepatic disorders

    Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8403844

    Methods for interventions

    Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is intervention?

intervention is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.